Chair of Pharmaceutical/Medicinal Chemistry, Institute of Pharmacy, Friedrich-Schiller-University Jena, Philosophenweg 14, Jena 07743, Germany.
Biotechnol Adv. 2018 Nov 1;36(6):1709-1723. doi: 10.1016/j.biotechadv.2018.02.010. Epub 2018 Feb 15.
Non-steroidal anti-inflammatory drugs (NSAIDs) inhibit prostanoid formation and represent prevalent therapeutics for treatment of inflammatory disorders. However, NSAIDs are afflicted with severe side effects, which might be circumvented by more selective suppression of pro-inflammatory eicosanoid biosynthesis. This concept led to dual inhibitors of microsomal prostaglandin E synthase (mPGES)-1 and 5-lipoxygenase that are crucial enzymes in the biosynthesis of pro-inflammatory prostaglandin E and leukotrienes. The potential of their dual inhibition in light of superior efficacy and safety is discussed. Focus is placed on natural products, for which direct inhibition of mPGES-1 and leukotriene biosynthesis has been confirmed.
非甾体抗炎药(NSAIDs)抑制前列腺素的形成,是治疗炎症性疾病的常用疗法。然而,NSAIDs 存在严重的副作用,通过更有选择性地抑制促炎类二十烷酸生物合成可以避免这些副作用。这一概念导致了环氧合酶-1 和 5-脂氧合酶的双重抑制剂(mPGES-1 和 5-脂氧合酶)的出现,这两种酶是促炎前列腺素 E 和白三烯生物合成中的关键酶。本文讨论了其双重抑制在提高疗效和安全性方面的潜力。重点介绍了已被证实可直接抑制 mPGES-1 和白三烯生物合成的天然产物。